AMR-Clinical Trials*

Investigational Alopecia Areata Trials – South Carolina, Utah and Florida

AMR-Clinical is conducting clinical research studies for adolescents 12 to 17 and adults 18 and older with a diagnosis of alopecia areata. The investigational drug is Ritlecitinib (Litfulo) which is already an FDA approved treatment for alopecia areata. This study is testing it out at a higher dose.

Qualified Participants Must

  • Have a diagnosis of alopecia areata
  • Be experiencing hair loss that began within the last 10 years
  • Meet other study criteria

Qualified participants will receive all study-related care at no cost. Compensation is available up to $1,350.00 for all study-related costs.

Apply Today

South Carolina

To apply for the South Carolina location:

Utah

To apply for the Utah location:

AMR Clinical Layton

Florida

To apply for the Florida location:

AMR Clinical Fort Myers

* At AMR Clinical, we’re committed to doing research right. With over 30 years of experience, 150,000+ participants enrolled, and 8,000+ trials completed across all phases, we’re equipped to exceed your expectations.

We aim to deliver quality health care with a participant-centered approach at our clinical trial centers. We provide a variety of clinical care and research services with compassion, while ensuring exceptional participant care and safety. Our experienced and professional clinical research support staff are highly qualified and fully committed to engaging you and your physician as informed partners in everything we do!

Currently, our 3 clinics specializing in dermatology are enrolling participants in a clinical research study for adolescents 12 to 17 and adults 18 and older with a diagnosis of alopecia areata.